Anticoagulant treatment of patients with atrial fibrillation in primary health care

Scand J Prim Health Care. 1999 Mar;17(1):59-63. doi: 10.1080/028134399750002926.

Abstract

Objective: To determine the prevalence of anticoagulant (AC) treatment of patients with atrial fibrillation in primary health care. To identify complications in the same patients during 1 year.

Design: Cross-sectional study and 1-year follow-up.

Setting: Seven health centres with a total population of 164093.

Subjects: Five hundred and twenty-two anticoagulated patients with atrial fibrillation.

Results: The age-adjusted prevalence of AC treated patients with atrial fibrillation was 0.30%. Of the 522 patients, 240 were men, mean age 69.6 years; and 282 women, mean age 75.1 years. At the beginning of the study 85% and after 1 year 81% of the latest prothrombin time values were within recommended range. After 1 year 414 out of the 522 patients continued AC treatment. During the 1-year follow-up 62 patients had minor or major complications. Eleven patients (2.1%) had to discontinue AC treatment because of complications. Prothrombin tests were mainly taken at 3-4 week intervals.

Conclusion: High quality AC treatment is possible in the hands of general practitioners.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / epidemiology
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Family Practice* / statistics & numerical data
  • Female
  • Finland / epidemiology
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Prevalence
  • Quality of Health Care*

Substances

  • Anticoagulants